Aurora Bio revealed data from the use of its AUR01 novel PET radiotracer for systemic amyloidosis that showed strong results in uptake and retention, but also experienced some adverse events. The synthetic peptide radiotracer is designed to bind many forms of amyloid, including AL, ATTR and ALECT2. Currently, no radiotracers are approved in the U.S. […]